Case Report: Durable disease stability in a patient with MET exon 14 skipping mutation and brain metastasis NSCLC following radiotherapy and immunotherapy
The combination of brain radiotherapy and camrelizumab demonstrated efficacy in a lung adenocarcinoma patient with BM and METex14. These findings suggest that immunotherapy may represent a potential treatment approach for high PD-L1 expression of METex14 NSCLC patients, warranting further investigation in larger cohorts.
Authors
- Dongfang Meng (ORCID: https://orcid.org/0000-0001-7250-1742)
- Ji Ma
- Yang Cui
- Depeng Zhang
- Zhigang Wei
- Xin Ye
Institutions
- Shandong University (CN)
- Shandong Tumor Hospital (CN)
- Boxing People's Hospital (CN)
- Shandong Provincial QianFoShan Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-02-03
- DOI
- https://doi.org/10.3389/fimmu.2026.1719029
- Citations
- 1
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 36.44
Funders
- National Natural Science Foundation of China